A screening-oriented blood test for cancer will quite possibly prove to be a nightmare. It very likely will not tell you where the cancer is located - just that it exists. It will also likely not detect highly localized tumors given they are thought not to produce circulating tumor cells.
So it is at least plausible that such a test will greatly increase worry, scans, surgery and chemo without having a dramatic impact on outcomes.
Liquid testing for tumors being treated can only be good though. Being able to detect mutations without biopsies will be a significant step forwards.